Inhibition and escape of SARS-CoV treated with antisense morpholino oligomers.
Neuman
Benjamin W
BW
The Scripps Research Institute, La Jolla, California, USA.
Stein
David A
DA
Kroeker
Andrew D
AD
Moulton
Hong M
HM
Bestwick
Richard K
RK
Iversen
Patrick L
PL
Buchmeier
Michael J
MJ
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology; D001665:Binding Sites; D006801:Humans; D019590:Nucleocapsid Proteins / Q000378:metabolism; D016376:Oligonucleotides, Antisense / Q000737:chemistry* / Q000235:genetics; D011485:Protein Binding; D045473:Severe acute respiratory syndrome-related coronavirus / Q000235:genetics*; D045169:Severe Acute Respiratory Syndrome / Q000235:genetics* / Q000628:therapy*
D000998:Antiviral Agents; D019590:Nucleocapsid Proteins; D016376:Oligonucleotides, Antisense